Literature DB >> 2018500

Insulin downregulates the steady-state level of its receptor's messenger ribonucleic acid.

A M Rohilla1, C Anderson, W M Wood, P Berhanu.   

Abstract

The effects of insulin on the steady-state level of human insulin receptor (hIR) mRNA were examined in the HepG2 human liver cell line using Northern blot analysis of either total cellular or poly(A)+ RNA. In control cells, up to six (4.5, 5.2, 7.4, 8.5, 9.4 and 10.8 kb) hybridizable species of hIR mRNA were identified, with the 8.5 and 10.8 kb species being most prominent. Incubation for 18 hrs with 1 microM insulin resulted in a similar decrease (to approximately 35% of control) of all the hIR mRNA species. The insulin effect was dose-dependent and was half-maximal by 2-3 hrs and maximal by 4-6 hrs of incubation at 37 degrees C. The hIR mRNA levels remained maximally insulin suppressed for up to 18 hrs but thereafter the effect became attenuated. These results indicate that insulin downregulates the level of hIR mRNA with a biphasic time-course and that this process is most likely part of the general mechanism by which insulin maintains the homeostatic control of its cellular receptor levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018500     DOI: 10.1016/0006-291x(91)91595-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.

Authors:  F Anfosso; N Chomiki; M C Alessi; P Vague; I Juhan-Vague
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

2.  Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model.

Authors:  Xue Li; Xiaoyun Xie; Weishuai Lian; Rongfeng Shi; Shilong Han; Haijun Zhang; Ligong Lu; Maoquan Li
Journal:  Exp Mol Med       Date:  2018-04-13       Impact factor: 8.718

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.